Journal of Artificial Organs

, Volume 21, Issue 2, pp 254–260 | Cite as

Investigation of adverse events associated with an off-label use of arterial stents and CE-marked iliac vein stents in the iliac vein: insights into developing a better iliac vein stent

Original Article Others
  • 86 Downloads

Abstract

We analyzed the adverse events associated with an off-label use of arterial stents and CE-marked iliac vein stents for the treatment of iliac venous thromboembolism and investigated their relationships with the anatomical features of the iliac vein, to gain insights into the development of a better iliac vein stent. Reports of adverse events following the use of stents in the iliac vein were retrieved from the Manufacturer and User Facility Device Experience (MAUDE) database that contain suspected device-associated complications reported to the Food and Drug Administration. Data from 2006 to 2016 were investigated. The literature analysis was also conducted using PubMed, Cochrane Library, EMBASE, and Web of Science focusing on English articles published up to 4 October 2016. The analysis of 88 adverse events from the MAUDE database and 182 articles from the literature revealed that a higher number of adverse events had been reported following the use of arterial stents in the iliac vein compared to CE-marked iliac vein stents. While stent migration and shortening were reported only for the arterial stents, stent fracture and compression occurred regardless of the stent type, even though a vein does not pulsate. A study of the anatomical features of the iliac vein implies that bending, compression, and kink loads are applied to the iliac vein stents in vivo. For designing, developing, and pre-clinical testing of stents intended for use in the iliac vein, the above mechanical load environments induced by the anatomical features should be considered.

Keywords

Venous thromboembolism Iliac vein stent Adverse event Off-label use Iliac vein anatomy 

Notes

Acknowledgements

This research was partially supported by the Research on Regulatory Science of Pharmaceuticals and Medical Devices from Japan Agency for Medical Research and development, AMED (no. 17mk0102087h0001), and Subsidy Program for Development of International Standards for Evaluation of Innovative Medical Devices and Regenerative Medicine Products, 2017 from Ministry of Health, Labour and Welfare, Japan.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Heit JA, Cohen AT, Anderson FA. Estimate annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE) events in the US. Blood. 2005;106:910.Google Scholar
  2. 2.
    Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Brecht JG, Greer IA, Heit JA, Hutchinson JL, Kakkar AK, Mottier D, Oger E, Samama MM, Spannagl M. Venous thromboembolism (VTE) in Europe. Thromb Haemost. 2007;98:756–64.CrossRefPubMedGoogle Scholar
  3. 3.
    Sakuma M, Nakamura M, Yamada N, Ota S, Shirato K, Nakano T, Ito M, Kobayashi T. Venous thromboembolism-deep vein thrombosis with pulmonary embolism, deep vein thrombosis alone, pulmonary embolism alone. Circ J. 2009;73:305–9.CrossRefPubMedGoogle Scholar
  4. 4.
    May R, Thurner J. The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology. 1957;8:419–27.CrossRefPubMedGoogle Scholar
  5. 5.
    Mickley V, Schwagierek R, Rillinger N, Gorich J, Sunder-Plassmann L. Left iliac venous thrombosis caused by venous spur: treatment with thrombectomy and stent implantation. J Vasc Surg. 1998;28:492–7.CrossRefPubMedGoogle Scholar
  6. 6.
    Jeon UB, Chung JW, Jae HJ, Kim HC, Kim SJ, Ha J, Park JH. May–Thurner syndrome complicated by acute iliofemoral vein thrombosis: helical CT venography for evaluation of long-term stent patency and changes in the iliac vein. AJR. 2010;195:751–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Cho H, Kim JW, Hong YS, Lim SH, Won JH. Stent compression in iliac vein compression syndrome associated with acute ilio-femoral deep vein thrombosis. Korean J Radiol. 2015;16:723–8.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Neglen P, Tackett TP Jr, Raju S. Venous stenting across the inguinal ligament. J Vasc Surg. 2008;48:1255–61.CrossRefPubMedGoogle Scholar
  9. 9.
    Funatsu A, Shibata K, Yamamoto R, Ono T, Mizobuchi M, Yokouchi I, Kanbayashi D, Kobayashi T, Enjoji Y, Nakamura S. Initial and long term outcomes of stent implantation for iliac compression syndrome. J Cardiol. 2007;50:371–7.PubMedGoogle Scholar
  10. 10.
    Raju S, Tackett P Jr, Neglen P. Reinterventions for nonocclusive iliofemoral venous stent malfunctions. J Vasc Surg. 2009;49:511–8.CrossRefPubMedGoogle Scholar
  11. 11.
    de Graaf R, de Wolf MA, Sailer AM, van Laanen J, Wittens C, Jalaie H. Iliocaval confluence stenting for chronic venous obstructions. Cardiovasc Interv Radiol. 2015;38:1198–204.CrossRefGoogle Scholar
  12. 12.
    Gutzeit A, Zollikofer ChL, Dettling-Pizzolate M, Graf N, Largiader J, Binkert CA. Endovascular stent treatment for symptomatic benign iliofemoral venous occlusive disease: long-term results 1987–2009. Cardiovasc Interv Radiol. 2011;34:542–9.CrossRefGoogle Scholar
  13. 13.
    Raju S, Ward M Jr, Kirk O. A modification of iliac vein stent technique. Ann Vasc Surg. 2014;28:1485–92.CrossRefPubMedGoogle Scholar
  14. 14.
    El Feghaly M, Soula P, Rousseau H, Chaiban F, Otal P, Joffre F, Cerene A. Endovascular retrieval of two migrated venous stents by means of balloon catheters. J Vasc Surg. 1998;28:541–6.CrossRefPubMedGoogle Scholar
  15. 15.
    Liu Z, Gao N, Shen L, Yang J, Zhu Y, Li Z, Si Y. Endovascular treatment for symptomatic iliac vein compression syndrome: a prospective consecutive series of 48 patients. Ann Vasc Surg. 2014;28:695–704.CrossRefPubMedGoogle Scholar
  16. 16.
    Knipp BS, Ferguson E, Williams DM, Dasika NJ, Cwikiel W, Henke PK, Wakefield TW. Factors associated with outcome after interventional treatment of symptomatic iliac vein compression syndrome. J Vasc Surg. 2007;46:743–9.CrossRefPubMedGoogle Scholar
  17. 17.
    Raju S. Long-Term outcomes of stent placement for symptomatic nonthrombotic iliac vein compression lesions in chronic venous disease. J Vasc Interv Radiol. 2012;23:497–502.CrossRefGoogle Scholar
  18. 18.
    Hartung O, Otero A, Boufi M, De Caridi G, Barthelemy P, Juhan C, Alimi YS. Mid-term results of endovascular treatment for symptomatic chronic nonmalignant iliocaval venous occlusive disease. J Vasc Surg. 2005;42:1138–44.CrossRefPubMedGoogle Scholar
  19. 19.
    Mullens W, De Keyser J, Van Dorpe A, Meuris B, Flamenq W, Herregods MC, Van de Werf F. Migration of two venous stents into the right ventricle in a patient with May–Thurner syndrome. Inter J Cardiol. 2006;110:114–5.CrossRefGoogle Scholar
  20. 20.
    Ashar RM, Huettl EA, Halligan R. Percutaneous retrieval of a wallstent from the pulmonary artery following stent migration from the iliac vein. J Interv Cardiol. 2002;15:101–6.CrossRefPubMedGoogle Scholar
  21. 21.
    Kwak HS, Han YM, Lee YS, Jin GY, Chung GH. Stents in common iliac vein obstruction with acute ipsilateral deep venous thrombosis: early and late results. J Vasc Interv Radiol. 2005;16:815–22.CrossRefPubMedGoogle Scholar
  22. 22.
    de Wolf MA, de Graaf R, Kurstjens RL, Pennix S, Jalaie H, Wittens CH. Short-term clinical experience with a dedicated venous nitinol stent: initial results with the sinus-venous stent. Eur J Vasc Endovasc Surg. 2015;50:1–9.CrossRefGoogle Scholar
  23. 23.
    de Graaf R, van Laanen J, Sailer A, Tordoir J. Long segment recanalization and dedicated central venous stenting in an ultimate attempt to restore vascular access central vein outflow. J Vasc Access. 2014;15:109–13.CrossRefGoogle Scholar
  24. 24.
    Bozkaya H, Cinar C, Ertugay S, Korkmaz M, Guneyli S, Posacioqlu H, Parildar M. Endovascular treatment of iliac vein compression (May–Thurner) syndrome: angioplasty and stenting with or without manual aspiration thrombectomy and catheter-directed thrombolysis. Ann Vasc Dis. 2005;8:21–8.CrossRefGoogle Scholar
  25. 25.
    Ye K, Lu X, Jiang M, Yang X, Li W, Huang Y, Huang X, Lu M. Technical details and clinical outcomes of transpopliteal venous stent placement for postthrombotic chronic total occlusion of the iliofemoral vein. J Vasc Interv Radiol. 2014;25:925–32.CrossRefPubMedGoogle Scholar
  26. 26.
    Holper P, Kotelis D, Attigah N, Hyhlik-Durr A, Bockler D. Longterm results after surgical thrombectomy and simultaneous stenting for symptomatic iliofemoral venous thrombosis. Eur J Vasc Endovasc Surg. 2010;39:349–55.CrossRefPubMedGoogle Scholar
  27. 27.
    Igari K, Kudo T, Toyofuku T, Jibiki M, Inoue Y. Surgical thrombectomy and simultaneous stenting for deep venous thrombosis caused by iliac vein compression syndrome (May–Thurner Syndrome). Ann Thoracic Cardiovasc Surg. 2014;20:995–1000.CrossRefGoogle Scholar
  28. 28.
    Titus JM, Moise MA, Bena J, Lyden SP, Clair DG. Iliofemoral stenting for venous occlusive disease. J Vasc Surg. 2011;53:706–12.CrossRefPubMedGoogle Scholar
  29. 29.
    Oguzkurt L, Tercan F, Pourbaqher MA, Kizilkilic O, Turkoz R, Boyvat F. Computed tomography findings in 10 cases of iliac vein compression (May–Thurner) syndrome. Eur J Radiol. 2005;55:421–5.CrossRefPubMedGoogle Scholar
  30. 30.
    Kibbe MR, Ujiki M, Goodwin AL, Eskandari M, Yao J, Matsumura J. Iliac vein compression in an asymptomatic patient population. J Vasc Surg. 2004;39:937–43.CrossRefPubMedGoogle Scholar
  31. 31.
    Takahashi N, Hosoi Y, Matsukura M, Nunokawa M, Kubota H. Influence of iliac vein compression on subsequent recanalization after deep venous thrombosis. J Jpn Coll Angiol. 2013;53:23–8.CrossRefGoogle Scholar
  32. 32.
    Roddy SP. Percutaneous recanalization of total occlusions of the iliac vein. J Vasc Surg. 2009;50:360–8.CrossRefGoogle Scholar
  33. 33.
    Comerota AJ, Grewal NK, Thakur S, Assi Z. Endovenectomy of common femoral vein and intraoperative iliac vein recanalization for chronic iliofemoral venous occlusion. J Vasc Surg. 2010;52:243–7.CrossRefPubMedGoogle Scholar
  34. 34.
    O’Sullivan GJ, Semba CP, Bittner CA, Kee ST, Razavi MK, Sze DY, Dake MD. Endovascular management of iliac vein compression (May–Thurner) syndrome. J Vasc Interv Radiol. 2000;11:823–36.CrossRefPubMedGoogle Scholar
  35. 35.
    Mahnkern AH, Thomson K, de Haan M, O’Sullivan GJ. CIRSE standards of practice guidelines on iliocaval stenting. Cardiovasc Interv Radiol. 2014;37:889–97.Google Scholar
  36. 36.
    Andrews RT, Venbrux AC, Magee CA, Bova DA. Placement of a flexible endovascular stent across the femoral joint: an in vivo study in the swine model. J Vasc Interv Radiol. 1999;10:1219–28.CrossRefPubMedGoogle Scholar
  37. 37.
    Matsuhashi Y, Sameshima K, Yamamoto Y, Umezu M, Iwasaki K. Investigation of the influence of fluid dynamics on thrombus growth at the interface between a connector and tube. J Artif Organs. 2017;20:293–302.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© The Japanese Society for Artificial Organs 2018

Authors and Affiliations

  1. 1.Joint Graduate School of Tokyo Women’s Medical University and Waseda University, Cooperative Major in Advanced Biomedical Sciences, Graduate School of Advanced Science and EngineeringWaseda UniversityTokyoJapan
  2. 2.Faculty of Science and EngineeringWaseda UniversityTokyoJapan

Personalised recommendations